What is Ivosidenib Drugs Market Scope?
This is the drug that is sold under the brand name of Tibsovo. This is the medication that is used to treat myeloid leukemia. The drug is still in development by Agios Pharmaceuticals and is in the third phase of the trial. Ivosidenib drug is used for the newly diagnosed. This tablet can be taken with or without food intake. The medicine should not be stopped unless prescribed by the doctor. There should not be any extra dose taken if missed. The drug also has some side effects which is restricting the growth of the market.
The Ivosidenib Drugs market study is being classified by Type (60 Tablets and 30 Tablets), by Application (Hospital and Pharmacy) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Agios Pharmaceuticals (United States) are some of the key players profiled in the study.
Analyst at AMA have segmented the market study of Global Ivosidenib Drugs market by Type, Application and Region.
On the basis of geography, the market of Ivosidenib Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On May 2, 2019, the Food and Drug Administration (FDA) had thereby approved the drug named Ivosidenib (TIBSOVO, Agios Pharmaceuticals, Inc.) for the purpose of recently diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation tested in the patients, who are of 75 years or are older and have comorbidities, that henceforth prevent the use of intensive induction chemotherapy.
Influencing Market Trend
- A Rise in The Smoking Habits of Younger Generation
- Increase in The Cases of Myeloid Leukaemia
- Rising Cases in Liver, Spleen, Brain and Spinal Cord
- A Rise in the Cases of Genetic Disorders
- Growing Improvements and Developments Across the Healthcare Industry
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Ivosidenib Drugs, Suppliers and Distributors of Ivosidenib Drugs, Venture Capitalists and Private Equity Firms and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.